Metabolism-modulating nanoparticles for remodeling adipose-liver crosstalk to reverse liver fibrosis.
Saved in:
| Title: | Metabolism-modulating nanoparticles for remodeling adipose-liver crosstalk to reverse liver fibrosis. |
|---|---|
| Authors: | Zhang LF; State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China., Liang SQ; State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China., Huang QW; State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China., Ru JW; State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China., Ding ZQ; Department of Pediatric Surgery, Children's Hospital of Nanjing Medical University, Nanjing 210000, China., Zhang CY; State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China., Wang Y; State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China., Zhou TJ; State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China., Xing L; State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China. Electronic address: xinglei6xl@cpu.edu.cn., Cheng XW; Provincial Key Laboratory of Stress and Cardiovascular Disease, Department of Cardiology and Hypertension, Yanbian University Hospital, Yanji 133000, China. Electronic address: chengxw@ybu.edu.cn., Oh YK; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea., Jiang HL; State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China; Provincial Key Laboratory of Stress and Cardiovascular Disease, Department of Cardiology and Hypertension, Yanbian University Hospital, Yanji 133000, China; College of Pharmacy, Yanbian University, Yanji 133002, China; Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, China Pharmaceutical University, Nanjing 210009, China; Department of Precision Medicine, School of Medicine, Sungkyunkwan University, Suwon 16419, Republic of Korea; Joint International Research Laboratory of Target Discovery and New Drug Innovation, MOE, Nanjing 210009, China. Electronic address: jianghulin3@cpu.edu.cn. |
| Source: | Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2026 Jul 10; Vol. 395, pp. 115026. Date of Electronic Publication: 2026 May 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
